Low frequency of HNPCC-Associated Microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer

American Journal of Clinical Pathology

Volumn 142, Issue 5, 2014, Pages 634-639

  Giedl, Johannes ^a   Schneckenpointner, Roland ^b   Filbeck, Thomas ^a   Ruemmele, Petra ^c   Hofstaedter, Ferdinand ^c   Burger, Maximilian ^d   Hartmann, Arndt ^a   Stoehr, Robert ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Donaustauf Hospital   (Germany)

^c Institute for Pathology   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Bladder cancer; Early onset; Lynch syndrome; Microsatellite instability

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; TUMOR PROTEIN;

ADULT; ARTICLE; BLADDER CANCER; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; FREQUENCY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; ADOLESCENT; AGE; AGED; BLADDER TUMOR; GENETICS; METABOLISM; MIDDLE AGED; MISMATCH REPAIR; MUTATION; ONSET AGE; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84922220662     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPVTCJ4VU5HKVZ     Document Type: Article

References (24)

1. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, et al. Epidemiology of urinary bladder cancer: from tumor development to patients death. World J Urol. 2007;25:285-295.
2. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234-241.
3. Paner GP, Zehnder P, Amin AM, et al. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: A comprehensive review of the literature with implications for patient management. Adv Anat Pathol. 2011;18:79-89.
4. Barrow E, Hill J, Evans DG. Cancer risk in Lynch syndrome. Fam Cancer. 2013;12:229-240.
5. van der Post RS, Kiemeney LA, Ligtenberg MJ, et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet. 2010;47:464-470.
6. Engel C, Loeffler M, Steinke V, et al. Risk of less common cancer in proven mutation carriers with Lynch syndrome. J Clin Oncol. 2012;30:1695-1705.
7. Eble JN, Sauter G, Epstein JI, et al., eds. Classification of Tumours: Pathology and Genetics of the Tumours of the Urinary System and Male Genital Organs. Lyon, France: World Health Organization; 2004:89-158.
8. Stoehr R, Zietz S, Burger M, et al. Deletions of chromosomes 9 and 8p in histologically normal urothelium in patients with bladder cancer. Eur Urol. 2005;47:58-63.
9. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
10. Wild PJ, Giedl J, Stoehr R, et al. Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger. J Pathol. 2007;211:18-25.
11. Schlegel J, Bocker T, Zirngibl H, et al. Detection of microsatellite instability in human colorectal carcinoma using a non-radioactive PCR-based screening technique. Virchows Arch. 1995;426:223-227.
12. Denzinger S, Burger M, Hammerschmied CG, et al. Pax-5 protein expression in bladder cancer: A preliminary study that shows no correlation to grade, stage, or clinical outcome. Pathology. 2008;40:465-469.
13. Hartmann A, Zanardo L, Bocker-Edmonston T, et al. Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res. 2002;62:6796-6802.
14. Mongiat-Artus P, Miquel C, van der Aa M, et al. Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients. Eur Urol. 2006;49:685-690.
15. Christensen M, Jensen MA, Wolf H, et al. Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer. Int J Cancer. 1998;79:396-401.
16. Migaldi M, Sartori G, Rossi G, et al. Prevalence and prognostic significance of microsatellite alterations in young patients with bladder cancer. Mod Pathol. 2005;18:1176-1186.
17. Catto JWF, Xinarianos G, Burton JL, et al. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer. 2003;105:484-490.
18. Gonzalez-Zulueta M, Ruppert MJ, Tokino K, et al. Microsatellite instability in bladder cancer. Cancer Res. 1993;53:5620-5623.
19. Bonnal C, Ravery V, Toublanc M, et al. Absence of microsatellite instability in transitional cell carcinoma of the bladder. Urology. 2000;55:287-291.
20. Stigliano V, Sanchez-Mete L, Matrayan A, et al. Early-onset colorectal cancer patients without family history are at very low risk for Lynch syndrome. J Exp Clin Cancer Res. 2014;33:1.
21. Kuligina ES, Morreau N, Imianitov EN. Microsatellite instability of bilateral breast carcinomas is not linked to down-regulated expression of DNA mismatch repair genes. Vopr Onkol. 2010;56:152-155.
22. Diniz G, Aktas S, Cubuk C, et al. Tissue expression of hMLH1, PMS2, hMSH2, and hMSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases. Pediatr Hematol Oncol. 2013;30:273-284.
23. Chauhan DP, Yang Q, Carethers JM, et al. Antisense inhibition of hMLH1 is not sufficient for loss of DNA mismatch repair function in the HCT116+ chromosome 3 cell line. Clin Cancer Res. 2000;6:3821-3831.
24. Shin KH, Park JG. Microsatellite instability is associated with genetic alteration but not with low levels of expression of human mismatch repair proteins hMSH2 and hMLH1. Eur J Cancer. 2000;36:925-931.